Figure 2Progression of AD based on pathology, MRI, and the amyloid-sensitive Probe, [18F] FDDNP PET
Neurofibrillary tangles, one of the molecular hallmarks of AD, tend to spread in the brain in a characteristic advancing trajectory (top row; adapted from (Braak and Braak, 1991)). Darker red colours denote areas with greater tangle deposition, based on histologic staining of post mortem material. On MRI, the areas with gray matter deficits in mild AD include primarily the temporal lobe, but in moderate AD these deficits have spread to involve the frontal cortex (middle row; adapted from a longitudinal study by (Thompson et al., 2003)). Finally, cerebral amyloid estimated in vivo from the PET ligand FDDNP is low in controls, but higher in those with impaired cognition (bottom row; adapted from (Braskie et al., 2008)). The anatomical agreement is striking between these in vivo maps and the well-established post mortem maps for the staging of AD. In all maps, the sensorimotor cortex shows least disease-related degeneration. [Adapted, with permission of the authors and publishers.]